Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 779-786     DOI: 10.31083/j.rcm2203084
Special Issue: Acute Coronary Syndromes in the Octogenarians
Review Previous articles | Next articles
Non-ST segment elevation myocardial infarction in the elderly
César Jiménez-Méndez1, †, Pablo Díez-Villanueva1, *, †(), Fernando Alfonso1
1Cardiology Department, Hospital Universitario La Princesa, Universidad Autónoma de Madrid, 28006 Madrid, IIS-IP, CIBER-CV, Spain
Download:  PDF(685KB)  ( 229 ) Full text   ( 21 )
Export:  BibTeX | EndNote (RIS)      
Ischemic heart disease constitutes the leading cause of death in Western countries. The general incidence of acute coronary syndromes (ACS), especially non-ST segment elevation myocardial infarction (NSTEMI), is growing. Advanced age is both a strong risk factor for ACS and an independent predictor of poorer clinical outcomes. Management of this entity is often complex in the elderly, while special attention should be focused on comorbidities and geriatric conditions. This article aims to review clinical presentation, identification and management of NSTEMI in the elderly population.
Key words:  Acute coronary syndrome      Elderly      Non-ST segment elevation myocardial infarction     
Submitted:  29 June 2021      Revised:  12 August 2021      Accepted:  17 August 2021      Published:  24 September 2021     
*Corresponding Author(s):  Pablo Díez-Villanueva     E-mail:
About author:  These authors contributed equally.

Cite this article: 

César Jiménez-Méndez, Pablo Díez-Villanueva, Fernando Alfonso. Non-ST segment elevation myocardial infarction in the elderly. Reviews in Cardiovascular Medicine, 2021, 22(3): 779-786.

URL:     OR

[1] Călin Pop, Diana Țînț, Antoniu Petris. Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 659-675.
[2] Leonardo De Luca, Luca Paolucci, Annunziata Nusca, Rita Lucia Putini, Fabio Mangiacapra, Enrico Natale, Gian Paolo Ussia, Furio Colivicchi, Francesco Grigioni, Francesco Musumeci, Domenico Gabrielli. Current management and prognosis of patients with recurrent myocardial infarction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 731-740.
[3] Yaowang Lin, Feng Liu, Shuying Gong, Bihong Liao, Huadong Liu, Jie Yuan, Danqing Yu, Haiyan Qin, Meishan Wu, Shaohong Dong. Validity of SOFA score as a prognostic tool for critically ill elderly patients with acute infective endocarditis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 967-973.
[4] Xiao-Fei Wang, Meng-Cheng Xu, Cheng-Yu Mao, En-Zhou, Qing He, Xing-Qian Qu, Yu-Qi Fan, Chang-Qian Wang, Jun-Feng Zhang. Predictive and prognostic value of v-set and transmembrane domain-containing 1 expression in monocytes for coronary artery disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1009-1017.
[5] Velimir S. Perić, Mladjan D. Golubović, Milan V. Lazarević, Tomislav L. Kostić, Dragana S. Stokanović, Miodrag N. Đorđević, Vesna G. Marjanović, Marija D. Stošić, Dragan J. Milić. Predictive potential of biomarkers and risk scores for major adverse cardiac events in elderly patients undergoing major elective vascular surgery[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1053-1062.
[6] Marco Schiavone, Federica Sabato, Cecilia Gobbi, Marialessia Denora, Lucrezia Zanchi, Alessio Gasperetti, Giovanni B. Forleo. Atrioventricular and intraventricular blocks in the setting of acute coronary syndromes: a narrative review[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 287-294.
[7] Nicholas C. Sanderson, William A. E. Parker, Robert F. Storey. Ticagrelor: clinical development and future potential[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 373-394.
[8] Rosa Agra-Bermejo, Alberto Cordero, Pedro Rigueiro Veloso, Diego Iglesias Álvarez, Belen Álvarez Álvarez, Brais Díaz, Leyre Alvarez Rodríguez, Charigan Abou-Jokh, Belén Cid Álvarez, Jose R. González-Juanatey, Jose M García Acuña. Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: real world evidence[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 475-482.
[9] Si-Yi Li, Ming-Gang Zhou, Tao Ye, Lian-Chao Cheng, Feng Zhu, Cai-Yan Cui, Yu-Mei Zhang, Lin Cai. Frequency of ST-segment elevation myocardial infarction, non-ST-segment myocardial infarction, and unstable angina: results from a Southwest Chinese Registry[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 239-245.
[10] Yu-Hao Zhao, Lei Zhao, Xin-Chun Yang, Pan Wang. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 159-165.
[11] Eric Bruckert, Gaelle Desamericq, Artak Khachatryan, Patrick Ngo, Gaelle Gusto, Francesc Sorio-Vilela. Patient characteristics, treatment patterns, and adherence to lipid-lowering therapies following an acute coronary syndrome[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 643-650.
[12] Gayatri Setia, Jeffrey Tyler, Alan Kwan, Josh Faguet, Shilpa Sharma, Siddharth Singh, Babak Azarbal, Rose Tompkins, Dinora Chinchilla, Sara Ghandehari. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 289-295.
[13] Mazen Odish, Tomasz Beben, Lori B. Daniels. False-positive Troponin I Assay elevation due to occult Mixed Cryoglobulinemic Vasculitis[J]. Reviews in Cardiovascular Medicine, 2018, 19(2): 73-75.
[14] Claudio Ronco, Federico Ronco, Peter A. McCullough. A Call to Action to Develop Integrated Curricula in Cardiorenal Medicine[J]. Reviews in Cardiovascular Medicine, 2017, 18(3): 93-99.
[15] Mehrnoosh Hashemzadeh, Joseph M. Arreguin, Tyler Roberts, Mohammad Reza Movahed. A Novel Inhibitor of Protease-activated Receptor 1: A Review of Chemical Structure and Mode of Action[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 68-73.
No Suggested Reading articles found!